Jim Cramer cherishes the moments when investors stop obsessing about the Federal Reserve, the Presidential election and overvaluation of stocks and just start buying up their favorite companies. It is rare that this occurs, but that is the gift that December brings.
"It's December and in December we get into what I call the era of good feelings. That is when you get a tacit deal between major investment firms and large institutional shareholders," the "Mad Money" host said.
Simply put, it is the understanding that analysts won't rock the boat and downgrade stocks at the end of the year. Especially when it could hurt the very accounts of hedge funds and mutual firms that the analysts cover. If analysts don't have anything nice to say, they shut up and save it for January.
The opposite rule goes into effect, too. If someone has something good to say, then they are encouraged to shout it from the rooftops.
"With December here, accept that Santa Claus does exist on Wall Street and he doesn't say ho ho ho, he says buy buy buy," Cramer said.
Read More Cramer: Santa does exist on Wall Street
Six months ago, Cramer reviewed the sexiest burger chains out there looking for the juiciest stocks. He highlighted McDonald's as a turnaround story, Jack in the Box as a value play and warned to stay the heck away from Shake Shack because of its insanely expensive price tag that would give any portfolio indigestion.
The "Mad Money" host took a victory lap on his call with McDonald's, Jack in the Box and Shake Shack. But the group has had a major shake-up lately. Jack in the Box rallied up to $97 in early August, and has been slammed back down to the low $70s a few months later. Meanwhile, Shake Shack has plummeted 42 percent in the past 6 months.
However, Cramer believes that the restaurant group may be poised to rally now that the price of gasoline has become so insanely low.
In the end, the winners of the burger wars for Cramer were the turnaround story at McDonald's, the value proposition at Jack in the Box, and the comeback potential of Red Robin. And while Cramer might like the burgers at Habit and Shake Shack, he's staying far away from the stocks.
Skechers is the once red-hot footwear company that missed Wall Street's sales and earnings estimates five weeks ago, which prompted the stock to lose 30 percent of its value in a single session.
But with a long track record for terrific execution, Cramer decided to check back in with its top executives to see if it could be turning things around.
"These guys are very competitive, which makes me think that they will do everything in their power to avoid having to report a second disappointing quarter in a row," Cramer said.
After plunging down to $25 a few weeks ago, the stock appears to have bottomed and has begun rebounding, up 4.8 percent on Tuesday.
To learn more, Cramer spoke with Skechers Chairman and CEO Robert Greenberg, and its CFO and COO David Weinberg.
"November is so strong now, and we have actually had a very, very good month. Our comps everywhere are mid-to-high single digits for the month, we had good sell outs, we had a great Singles Day in China which was more than double last year. So everything is moving along and pretty much on target," Weinberg said.
When Cramer starts to see stocks moving with no promotion whatsoever, he considers it to be a gift. That is exactly what is happening right now with the semiconductor stocks. They're making major breakout moves for absolutely no reason. No news, no data points, no analyst pushes — nothing!
"That kind of spontaneous combustion is the sort of thing I used to look for at my old hedge fund because I would sense that the analysts would see the action and then find reasons to recommend these stocks once they figured out something positive to say," the "Mad Money" host said.
One stock that has been quietly rallying is Intel. Though it has been totally off the radar, Cramer still thinks it is worth considering. Intel's stock has dropped due to its connection to the secular decline in personal computers.
But that challenge is much worse for a company like HP Inc. that actually makes computers, as opposed to Intel which just makes the processors inside. More importantly, Altera, the high-end semiconductor company, will soon become part of the Intel family and give the company a less-PC oriented and a more high growth profile.
"I think Intel will be a changed story, and its stock will get 're-rated,' meaning that analysts are going to rally behind this one because it is no longer a one-trick pony," Cramer said.
At a certain point, Cramer began to wonder if the biotech companies with tremendous pipelines and real prospects have been punished enough. The entire group has been in the doghouse for months due to scrutiny over expensively priced meditations.
But has the group become too cheap to ignore? To get a closer look on what the charts predict for this group Cramer turned to Bob Lang, a technician who is the founder and senior strategist at ExplosiveOptions.net and a colleague of Cramer's at RealMoney.com.
Lang noticed that big money has begun flowing back into three junior growth biotechs after a prolonged period of weakness. He selected Juno Therapeutics, Isis Pharmaceuticals and Blubird Bio. All three stocks were tremendous performers in 2014, but this year they have all done next to nothing.
But Lang things all three could soon be back in business, and could be ready to resume their long-term march after taking a breather in 2015.
In the Lightning Round, Cramer gave his take on a few caller favorite stocks:
Medical Properties Trust, Inc: "I'm not even going to go there because I've got Ventas. I've got Deb Cafaro [CEO] with that stock so cheap, you're pulling that one."
Pure Storage: "We liked it for a trade. We made the trade, and then we went away. But it's OK down here at $13."